Useful resources |
Cholinesterase inhibitors for Alzheimer's disease (Cochrane Review) ABSTRACT Background: Since the introduction of the first cholinesterase inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and rivastigmine, to be the first line pharmacotherapy for mild to mo . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |